文献速递脑血管病

年龄与基线ASPECTS评分对血栓切除术后临床结局的联合影响:MR CLEAN登记研究

Combined Effect of Age and Baseline Alberta Stroke Program Early Computed Tomography Score on Post-Thrombectomy Clinical Outcomes in the MR CLEAN Registry.
PubMed 文献 · Stroke · 2020-10-23

基于MR CLEAN登记研究3279例接受血管内治疗的急性缺血性卒中患者,探讨年龄与基线ASPECTS评分对功能结局的交互作用。结果显示年龄与ASPECTS无显著交互作用(P=0.925),尽管高龄且低ASPECTS患者不良结局比例最高,但再灌注获益在各年龄-ASPECTS亚组中均存在,不支持仅基于高龄和低ASPECTS组合而拒绝血管内治疗。

要点

  • 年龄与基线ASPECTS对功能结局无显著交互作用(P=0.925)。
  • 高龄(>71.8岁)且ASPECTS 0-5患者mRS 5-6比例最高(63.6%)。
  • 所有年龄-ASPECTS亚组均显示再灌注获益,不支持因高龄低ASPECTS拒绝治疗。

核心结论

  • 年龄与基线ASPECTS对血管内治疗后的功能结局无显著交互作用。
  • 尽管高龄且低ASPECTS患者不良结局比例最高,但再灌注获益在各亚组中均存在。
  • 结果不支持仅基于高龄和低ASPECTS组合而拒绝血管内治疗。

研究设计与样本

  • 基于MR CLEAN登记研究(2014年3月至2017年11月)的多中心回顾性分析。
  • 纳入3279例接受血管内治疗的急性缺血性卒中患者。
  • 采用多变量有序逻辑回归分析年龄与ASPECTS的交互作用。

主要发现

  • 年龄与ASPECTS对mRS的交互作用无统计学意义(P=0.925)。
  • 年龄>71.8岁且基线ASPECTS 0-5的患者mRS 5-6比例为63.6%(68/107)。
  • 年龄>71.8岁且ASPECTS 0-5亚组的调整共同比值比为1.60(95%CI 0.66-3.88,n=110),与主效应无显著差异(P=0.299)。
  • 所有年龄-ASPECTS亚组均观察到再灌注获益。

关键数值与推荐

  • 年龄中位数为71.8岁,亚组按年龄< vs ≥71.8岁和基线ASPECTS 6-10 vs 0-5划分。
  • 主要结局为modified Rankin Scale评分。
  • 交互作用检验P=0.925,亚组与主效应差异检验P=0.299。

临床怎么用

  • 对于高龄且基线ASPECTS较低的患者,不应仅因年龄和ASPECTS组合而拒绝血管内治疗。
  • 再灌注获益在各年龄-ASPECTS亚组中均存在,支持个体化评估。

局限性

  • 本研究为登记研究,可能存在选择偏倚和未测量混杂因素。
  • 亚组样本量较小(如年龄>71.8岁且ASPECTS 0-5组n=110),置信区间较宽。
  • 结论需在更广泛人群中进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Ischemic brain tissue damage in patients with acute ischemic stroke, as measured by the Alberta Stroke Program Early CT Score (ASPECTS) may be more impactful in older than in younger patients, although this has not been studied. We aimed to investigate a possible interaction effect between age and ASPECTS on functional outcome in acute ischemic stroke patients undergoing endovascular treatment, and compared reperfusion benefit across age and ASPECTS subgroups. METHODS: Patients with ischemic stroke from the MR CLEAN Registry (Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands; March 2014-November 2017) were included. Multivariable ordinal logistic regression was performed to obtain effect size estimates (adjusted common odds ratio) on functional outcome (modified Rankin Scale score) for continuous age and granular ASPECTS, with a 2-way multiplicative interaction term (age×ASPECTS). Outcomes in four patient subgroups based on age (< versus ≥ median age [71.8 years]) and baseline ASPECTS (6-10 versus 0-5) were assessed. RESULTS: We included 3279 patients. There was no interaction between age and ASPECTS on modified Rankin Scale (P=0.925). The highest proportion of modified Rankin Scale 5 to 6 was observed in patients >71.8 years with baseline ASPECTS 0 to 5 (68/107, 63.6%). There was benefit of reperfusion in all age-ASPECTS subgroups. Although the adjusted common odds ratio was lower in patients >71.8 years with ASPECTS 0 to 5 (adjusted common odds ratio, 1.60 [95% CI, 0.66-3.88], n=110), there was no significant difference from the main effect (P=0.299). CONCLUSIONS: Although the proportion of poor outcomes following endovascular treatment was highest in older patients with low baseline ASPECTS, outcomes did not significantly differ from the main effect. These results do not support withholding endovascular treatment based n a combination of high age and low ASPECTS.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Ospel J, Kappelhof M, Groot AE, et al. Combined Effect of Age and Baseline Alberta Stroke Program Early Computed Tomography Score on Post-Thrombectomy Clinical Outcomes in the MR CLEAN Registry. Stroke. 2020. PMID: 33092478. doi:10.1161/STROKEAHA.120.031773

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。